Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.165    -0.01 (-5.71%)
Bid:
0.16
Ask:
0.17
Spread: 0.01 (6.25%)
Market Cap: £2.18m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Small caps: Cineworld, Aortech, African Eagle

Mon, 24th May 2010 07:52
Cinema chain Cineworld has signed a deal with Quintain Estates for a new multi-screen cinema at Wembley City, the retail park next door to Wembley station. Cineworld has signed a 25 year lease for a new nine screen cinema which will seat 1,800 people in total and is scheduled to open in 2013. It will be located adjacent to Wembley Stadium and Wembley Arena, forming a central part of the 280,000 sq ft leisure and retail hub. Construction is expected to commence on the site in 2011.Biomaterials and medical devices group Aortech today announced a non-exclusive technology licence and material supply agreement with a multi-billion dollar NYSE listed company to use the group's proprietary biostable co-polymer Elast-Eo as an integral part of a drug delivery platform for urological catheters.African Eagle is "delighted" with results of its phase 2 column and tank leach tests at the Dutwa nickel project in Tanzania.The tests show that Dutwa ore could be processed by either heap leaching or tank leaching at normal atmospheric pressure, without recourse to the high cost and hi-tech complications of high pressure acid leach (HPAL).Green technology company Ultima Networks made a pre-tax profit of £214,000 in 2009, down from £281,000 the previous year, on revenue down to £1.87m from £1.98m. "There remain challenges ahead in the economic conditions we face which will have an impact on all divisions of the business but we are confident that the milestones reached in 2009 will allow us to grow across all areas of the group," the firm said.It's also confident it will be able to raise enough money to build the solar parks planned for southern Italy.ValiRx, the biotech firm focused on cancer diagnostics and therapeutics for personalised medicine, has added an over the counter Chlamydia self-testing kit to its range of health screening products.The company has signed an agreement to market Biovei's Chlamydia kit in the UK and Ireland under ValiRx's SELFCheck brand. The SELFCheck Chlamydia kit will provide a test result within about 10 minutes, compared to a lag of four to five days for a laboratory test. Trading systems developer Patsystems said results for the year to end of April were in line with management's expectations while the company's strong pipeline underpins its belief that 2010 will be another strong year for the group."I am pleased to report that 2010 has started as strongly as we expected with the addition of Bursa Malaysia to our client list, good progress on several other sales prospects and continued double digit growth in our existing Asian client base," said Richard Last, the company's chairman.Oil and gas firm Roxi Petroleum narrowed pre-tax losses to $33.4m against the loss of $94.5m predominantly due to lower admin costs. "These are exciting times for Roxi and its shareholders, as we remain focused on increasing shareholder value in the near term. We are looking forward to a very active and productive period ahead of us," he said.Stratex International rose after the exploration and development company announced "positive results" from detailed sampling of the company's Megenta hot spring gold discovery in Ethiopia.Shares in Max Petroleum fell back after the Kazakhstan-focused oil and gas developer said reservoirs encountered during drilling at the Borkyldakty Field were 'structurally lower than expected, at or below their respective oil-water contacts.'

Related News

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal
22 Jun 2026

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
27 May 2026

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case
15 May 2026

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

ValiRx News

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit
30 Jun 2022

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

AIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license
30 Jun 2022

AIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

ValiRx expecting to grant extension of exclusivity to TheoremRx
17 Jun 2022

ValiRx expecting to grant extension of exclusivity to TheoremRx

(Sharecast News) - Cancer therapeutics and women's health-focussed ValiRx updated the market on its proposed sub-licensing agreement with TheoremRx fo...

AIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support
17 Jun 2022

AIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

ValiRx shares drop as cancer drug sub-licensing progress stalls
17 Jun 2022

ValiRx shares drop as cancer drug sub-licensing progress stalls

(Alliance News) - ValiRx PLC on Friday said it is expecting to be asked to extend the exclusivity period between itself and TheroemRx Inc regarding th...

IN BRIEF: ValiRx widens annual loss as R&D costs climb
7 Jun 2022

IN BRIEF: ValiRx widens annual loss as R&D costs climb

ValiRx PLC - Nuneaton, England-based drug development company - Widens pretax loss in 2021 to GBP1.7 million from GBP1.5 million the previous year. Re...

TRADING UPDATES: Arecor Therapeutics wins patent approval in US
23 Mar 2022

TRADING UPDATES: Arecor Therapeutics wins patent approval in US

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: